Hospital Admin Articles

Hospital Admin

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shaffer ER et al. – Millions of people lack access to affordable medicines. The intellectual property rules in the Central America Free Trade Agreement (CAFTA) provide pharmaceutical companies with monopoly protections that allow them to market some drugs without competition by less costly generics.

Related Articles

Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09    Relevance Score: 68%

Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09    Relevance Score: 68%

Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09    Relevance Score: 67%

Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
Diagnostic Microbiology and Infectious Disease, 10/22/09    Relevance Score: 67%

Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09    Relevance Score: 67%

Today in Law/Ethics/Regulations...keeping you current

I.T. Loan Guarantee Provision Hits House Floor
HealthDataManagement, 12/09/09

Testing the Health Records Bank Model
HealthDataManagement, 12/09/09

The effect of education on health among US residents in relation to country of birth
Health Economics, 12/08/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address